Fig. 5
From: Identification of a pyroptosis-related prognostic signature in breast cancer
Validation of risk signature in the TCGA and GEO cohorts separately. A Kaplan–Meier curves for the OS of patients in the high- and low-risk groups in the TCGA cohort. B ROC curves showed the predictive efficiency of the risk scores in the TCGA cohort. C Kaplan–Meier curves for the OS of patients in the high- and low-risk groups in the GEO cohort. D ROC curves showed the predictive efficiency of the risk scores in the GEO cohort. Kaplan–Meier curves for the OS of low-risk group is better than that of high-risk group in stage I-II (E, p < 0.001) and stage III-IV (F, p < 0.001) patients in the TCGA cohort